Capital World Investors Exact Sciences Corp Transaction History

Capital World Investors

$633 Billion
Q4 2024

A detailed history of Capital World Investors transactions in Exact Sciences Corp stock. As of the latest transaction made, Capital World Investors holds 17,537,617 shares of EXAS stock, worth $864 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

17,537,617

Previous 15,841,296 10.71%

Holding current value

$864 Million

Previous $1.08 Billion 8.64%

% of portfolio

0.16%

Previous 0.17%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$49.33 - $71.97 $83.7 Million - $122 Million	1,696,321 Added 10.71%	17,537,617 $985 Million
Q3 2024 Nov 13, 2024	SELL	$42.43 - $70.83 $28 Million - $46.8 Million	-660,050 Reduced 4.0%	15,841,296 $1.08 Billion
Q2 2024 Aug 13, 2024	BUY	$41.33 - $74.26 $144 Million - $258 Million	3,476,033 Added 26.69%	16,501,346 $697 Million
Q1 2024 May 14, 2024	BUY	$56.27 - $73.77 $313 Million - $410 Million	5,557,168 Added 74.41%	13,025,313 $900 Million
Q4 2023 Feb 13, 2024	BUY	$59.06 - $75.72 $31.9 Million - $40.9 Million	539,498 Added 7.79%	7,468,145 $552 Million
Q3 2023 Nov 13, 2023	BUY	$65.94 - $99.04 $8.62 Million - $12.9 Million	130,687 Added 1.92%	6,928,647 $473 Million
Q2 2023 Aug 11, 2023	BUY	$62.68 - $95.05 $10.9 Million - $16.5 Million	173,174 Added 2.61%	6,797,960 $638 Million
Q1 2023 May 15, 2023	BUY	$47.19 - $70.77 $67.6 Million - $101 Million	1,433,399 Added 27.61%	6,624,786 $449 Million
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $6 Million - $10.5 Million	197,698 Added 3.96%	5,191,387 $257 Million
Q3 2022 Nov 14, 2022	SELL	$31.97 - $49.37 $28.7 Million - $44.4 Million	-898,689 Reduced 15.25%	4,993,689 $162 Million
Q2 2022 Aug 15, 2022	BUY	$35.61 - $76.23 $14.4 Million - $30.9 Million	405,369 Added 7.39%	5,892,378 $232 Million
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $46.3 Million - $66.4 Million	804,159 Added 17.17%	5,487,009 $384 Million
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $93.3 Million - $130 Million	-1,286,462 Reduced 21.55%	4,682,850 $364 Million
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $34.6 Million - $47.6 Million	383,649 Added 6.87%	5,969,312 $570 Million
Q2 2021 Aug 16, 2021	SELL	$93.66 - $139.27 $264 Million - $393 Million	-2,822,123 Reduced 33.57%	5,585,663 $694 Million
Q1 2021 May 14, 2021	SELL	$116.57 - $155.01 $220 Million - $293 Million	-1,890,610 Reduced 18.36%	8,407,786 $1.11 Billion
Q4 2020 Feb 12, 2021	BUY	$99.61 - $142.12 $296 Million - $422 Million	2,967,886 Added 40.49%	10,298,396 $1.36 Billion
Q3 2020 Nov 13, 2020	BUY	$72.92 - $102.01 $470 Million - $657 Million	6,440,510 Added 723.65%	7,330,510 $747 Million
Q1 2018 May 15, 2018	SELL	$39.82 - $57.53 $34.2 Million - $49.5 Million	-860,000 Reduced 49.14%	890,000 $35.9 Million
Q3 2017 Nov 14, 2017	BUY	$37.05 - $47.12 $64.8 Million - $82.5 Million	1,750,000	1,750,000 $82.5 Million

Others Institutions Holding EXAS

# of Institutions

672

Shares Held

164M

Call Options Held

4.25M

Put Options Held

1.89M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.72B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account

Capital World Investors Exact Sciences Corp Transaction History